Page 78 - 南京医科大学自然版
P. 78

第45卷第12期
               ·1760 ·                           南 京    医 科 大 学 学         报                        2025年12月


                    A                                            B
                            MR Test
                              Inverse variance weighted  Weighted median
                              MR Egger           Weighted mode
                              Simple mode
                         0.10                                         0.05
                       SNP effect on acute pancreatitis  0.05       SNP effect on acute pancreatitis  0.00






                         0.00


                                                                     -0.05
                        -0.05
                                0.015   0.020   0.025   0.030               0.015   0.020   0.025   0.030
                                     SNP effect on αKG                            SNP effect on αKG

                    C    0.10                                    D
                       SNP effect on acute pancreatitis  -0.05      SNP effect on acute pancreatitis  -0.05
                         0.05
                                                                      0.00
                         0.00







                                 0.03    0.06    0.09                         0.03    0.06    0.09
                                 SNP effect on indolepropionate               SNP effect on indolepropionate

                         E
                           Study            log2OR SE(log2OR)  Odds ratio     OR     95%CI    Weight
                                            0
                           Exposure=alpha⁃ketoglutarate  0                    0        0      0
                           ebi⁃a⁃GCST90018789  1.017 3  0.415 8               2.77  1.22-6.25  55.5%
                           finn⁃b⁃K11_ACUTPANC  1.072 2  0.464 2              2.92  1.18-7.26  44.5%
                                     2    2
                           Heterogeneity:I =0%,t =0,P=0.93
                           Common effect model                                2.83  1.54-5.20  100.0%
                                                          0.2  0.5  1.0  2.0  5.0
                         F
                            Study            log2OR SE(log2OR)  Odds ratio     OR     95%CI    Weight
                                             0
                            Exposure=alpha⁃ketoglutarate  0                    0        0      0
                            ebi⁃a⁃GCST90018789  -2.562 4  0.193 7              0.57  0.39-0.83  64.3%
                            finn⁃b⁃K11_ACUTPANC  -0.725 1  0.259 6             0.48  0.29-0.81  35.7%
                                      2
                                           2
                            Heterogeneity:I =0%,t =0,P=0.62
                            Common effect model                                0.54  0.40-0.73  100.0%
                                                             0.5   1.0  2.0
                 A:Analysis of the relationship between serum αKG and the incidence of AP based on the ebi⁃a⁃GCST90018789 dataset,with different lines repre⁃
              senting various statistical methods. B:Analysis of the relationship between serum αKG and the incidence of AP based on the finnb⁃K11_ACUTPANC
              dataset. C:Analysis of the relationship between serum INDO and the incidence of AP based on the ebi⁃a⁃GCST90018789 dataset. D:Analysis of the rela⁃
              tionship between serum INDO and the incidence of AP based on the finnb⁃K11_ACUTPANC dataset. E:Two rounds Meta⁃analysis of the relationship
              between αKG and the incidence of AP based on the ebi⁃a⁃GCST90018789 and finnb⁃K11_ACUTPANC datasets. F:Two rounds Meta⁃analysis of the re⁃
              lationship between INDO and the incidence of AP based on the ebi⁃a⁃GCST90018789 and finnb⁃K11_ACUTPANC datasets.
                                             图1   αKG、INDO与AP发病因果关系分析图
                                Figure 1 Causal relationship analysis of αKG and INDO with the onset of AP
   73   74   75   76   77   78   79   80   81   82   83